Discovery of [18F]JK-PSMA-7 as PET-probe suitable for imaging of small PSMA expressing lesions

被引:0
|
作者
Zlatopolskiy, Boris [1 ]
Endepols, Heike [1 ]
Krapf, Philipp [2 ]
Guliyev, Mehrab
Urusova, Elizaveta [2 ]
Richarz, Raphael [2 ]
Hohberg, Melanie [3 ]
Dietlein, Markus [3 ]
Drzezga, Alexander [3 ]
Neumaier, Bernd [4 ]
机构
[1] Univ Hosp Cologne, Inst Radiochem & Expt Mol Imaging IREMB, Cologne, Germany
[2] Forschungszentrum Julich GmbH, Inst Neurosci & Med, INM Nucl Chem 5, Julich, Germany
[3] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[4] Forschungszentrum Julich GmbH, Julich, Germany
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
P-282
引用
收藏
页码:S442 / S443
页数:2
相关论文
共 50 条
  • [21] Quantitative parameters to discriminate indeterminate bone lesions on [18F]-PSMA-1007 PET/CT in prostate cancer imaging
    Sciuto, R.
    Maccora, D.
    Sanguineti, G.
    Faiella, A.
    Rea, S.
    Annovazzi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S543 - S543
  • [22] Fully Automated Production of (((S)-1-Carboxy-5-(6-([18F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-<sc>l</sc>-glutamic Acid ([18F]JK-PSMA-7)
    Krapf, Philipp
    Wicher, Thomas
    Zlatopolskiy, Boris D.
    Ermert, Johannes
    Neumaier, Bernd
    PHARMACEUTICALS, 2025, 18 (01)
  • [23] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Baris Turkbey
    Peter L. Choyke
    Nature Reviews Urology, 2020, 17 : 9 - 10
  • [24] [18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
    Loeff, Cato C.
    van Gemert, Willemijn
    Prive, Bastiaan M.
    van Oort, Inge M.
    Hermsen, Rick
    Somford, Diederik M.
    Nagarajah, James
    Heijmen, Linda
    Janssen, Marcel J. R.
    EJNMMI REPORTS, 2024, 8 (01)
  • [25] Evaluation And Preliminary Radiation Dosimetry Of [18F] PSMA-11 For PET Imaging Of Prostate Cancer
    Piron, S.
    De Man, K.
    Van Laeken, N.
    D'Asseler, Y.
    Kersemans, K.
    Ost, P.
    Decaestecker, K.
    Deseyne, P.
    Fonteyne, V.
    Lumen, N.
    Brans, B.
    De Vos, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S149 - S149
  • [26] Molecular Imaging of Prostate Cancer: A direct comparison of the preclinical characteristics of [18F] DCFPyL and [18F]PSMA-1007 and the impact of glutamic acids on [18F]PSMA-1007
    Roscher, M.
    Remde, Y.
    Schaefer, M.
    Bauder-Wuest, U.
    Giesel, F.
    Neels, O. C.
    Cardinale, J.
    Kopka, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S54 - S55
  • [27] Dose Reduced [18F]PSMA-1007 PET is Feasible for Functional Imaging of the Renal Cortex
    Valind, K.
    Brolin, G.
    Jogi, J.
    Minarik, D.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S339 - S340
  • [28] PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
    Ismail, Mohamed Saleh
    Peters, Diane E.
    Rowe, Steven P.
    Salavati, Ali
    Sharma, Sowmya
    Anders, Robert A.
    Pomper, Martin
    Slusher, Barbara S.
    Selaru, Florin M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2023, 16 : 237 - 247
  • [29] Comparison of PET/CT Imaging with [18F]PSMA-1007 and [18F]FDG in Muscle-Invasive Bladder Urothelial Carcinoma
    Ramos, C.
    Tineo, R.
    Avilez, N.
    Rodrigues, J.
    Saito, H.
    Leal, F.
    Amorim, B.
    Carvalheira, J.
    Reis, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S595 - S596
  • [30] Metastatic Superscan in 18F PSMA PET/CT of a Patient with Prostate Carcinoma
    Singh, Man Mohan
    Verma, Shashwat
    Kakkar, Lavish
    Deswal, Satyawati
    Thakur, Priyamedha Bose
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2024, 33 (01) : 38 - 39